Tussmuco
(2R)-2-Acetamido-3-sulfanylpropanoic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 12035.
Registration
- Applicants
- 1
- Registrations
- 2
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Tussmuco EACH TABLET CONTAINS ACETYLCYSTEINE 200,0 mg | Not listed | 54085454/10.3/0854 | Registered | Not determined | None |
| Tussmuco 600 EACH TABLET CONTAINS: ACETYLCYSTEINE 600,0 mg | 600 mgEffervescent tablets | 59010459/10.3/0104Approved 25 November 2025 | Registered | S1 | PIPIL |
Regulatory status
Where S1 sits on the scale
Sold by a pharmacist, no doctor's prescription needed.
Schedule 1 medicines are normally sold by a pharmacist, or by a supervised pharmacist intern or assistant, without a doctor's visit; a veterinarian, or a licensed dispensing doctor, dentist or nurse prescriber, may also supply them. A nurse or other non-doctor prescriber may only prescribe the specific substances the Schedule names for that purpose, and may only dispense them if licensed to do so. A child under 12 may only be sold one of these medicines on a prescription, or on a written order that names the purpose and carries a signature the seller recognises.
Schedule S1, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S3; the leaflet's S1 applies to this product.
Who may supply: A pharmacist, or a supervised pharmacist intern or assistant; manufacturers and wholesalers supplying people who may lawfully possess it; a veterinarian, who may prescribe, compound or dispense it; a medical practitioner or dentist, who may prescribe it, and may compound or dispense it only if licensed under section 22C(1)(a); a nurse or other registered non-doctor prescriber, who may prescribe only the Scheduled substances the Schedule identifies for that purpose, and dispense them if licensed to do so; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Acetylcysteine
S3: Acetylcysteine
- when intended for injection or for the management of paracetamol overdosage;
- except when used as a mucolytic in acute respiratory conditions for a maximum treatment period of 14 days. (S1)
Consolidated Schedules 06 July 2026, lines 3109 to 3114
S1: Acetylcysteine
- when used as a mucolytic in acute respiratory conditions for a maximum treatment period of 14 days;
- except when intended for injection or for the management of paracetamol overdosage. (S3)
Consolidated Schedules 06 July 2026, lines 102 to 106
Pharmacological class: Others. (class 10.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
Schedule Verification
Tussmuco 600, Pharmacare limited û woodmead is scheduled S1 in its official SAHPRA documents, read with 90% confidence.
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.